www.fdanews.com/articles/190541-fda-clears-epithelial-thickness-mapping-for-cirrus-platform
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
FDA Clears Epithelial Thickness Mapping for Cirrus Platform
March 12, 2019
The FDA granted 510(k) clearance to Carl Zeiss Meditec’s for inclusion of epithelial thickness mapping in its Cirrus HD-OCT platform, which offers solutions for various ophthalmic practices.
The device can perform optical coherence tomography (OCT), a non-invasive imaging test that uses light waves to take pictures of a patient’s retina.
The device’s new module helps identify patients eligible for refractive surgery and monitors how the cornea responds to post-surgical healing.